The high throughput screening market size has grown rapidly in recent years. It will grow from $20.66 billion in 2023 to $22.98 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth observed during the historic period can be attributed to several factors, including the increasing adoption of high-throughput screening techniques, a rise in Research and Development (R&D) spending across various industries, the growing availability of funds for research purposes, an increase in healthcare spending globally, and a competitive market landscape driving innovation and development in the field.
The high throughput screening market size is expected to see strong growth in the next few years. It will grow to $33.1 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth in the forecast period can be attributed to several key factors, including the expansion of the market size and growth rate, strategic initiatives undertaken by key industry players, a rising demand for disease monitoring and drug discovery solutions, the increasing prevalence of chronic diseases globally, and a growing emphasis on implementing ultra-high-throughput screening (UHTS) techniques. Major trends expected during this period include technological advancements in high-throughput screening methodologies and an increasing focus on the adoption of ultra-high-throughput screening (UHTS) techniques to enhance efficiency and throughput in various research and development processes.
The expansion in chronic illness prevalence is anticipated to drive the progression of the high-throughput screening (HTS) market in the future. Chronic diseases denote prolonged health conditions persisting over three months or more. HTS facilitates swift examination of numerous chemical compounds to identify potential drug candidates aimed at specific pathways or mechanisms linked to chronic ailments, crucial for their effective long-term control. For example, as per a report released by the National Library of Medicine in January 2023, the projected rise in individuals aged 50 and above with one or more chronic diseases in the United States is expected to soar by 99.5%, reaching 142.66 million by 2050, compared to 71.522 million in 2020.
Prominent enterprises operating within the high-throughput screening market are innovating their product lines to cater to their clientele with advanced functionalities. A multimode plate reader (MPR) represents an advanced laboratory apparatus employed in high-throughput screening, analyzing biological and chemical samples in microplates by integrating multiple detection modes for various assays within a unified platform. For instance, in February 2023, PerkinElmer Inc., a United States-based MedTech firm, unveiled the EnVision Nexus system. Positioned as the swiftest and most sensitive multimode plate reader in the market, the EnVision Nexus system is expressly crafted for demanding high-throughput screening (HTS) applications to accelerate drug discovery endeavors. Boasting distinctive technology, including dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, alongside cutting-edge reagent kits, the platform furnishes researchers with unmatched assay flexibility, precision, velocity, and sensitivity. Outfitted with user-friendly features such as a plate stacker for 20 or 50 plates and full automation and integration for uninterrupted 24/7 workflow-driven operations, the EnVision Nexus system empowers researchers to efficiently screen millions of samples with unprecedented efficiency.
In December 2023, PerkinElmer Inc., a prominent US-based MedTech firm, completed the acquisition of Covaris Inc. for an undisclosed sum. This strategic move is expected to expedite Covaris' growth trajectory, while simultaneously enabling PerkinElmer to broaden its footprint in the burgeoning diagnostics segment within the life sciences industry. Covaris Inc., renowned for its high-throughput screening solutions, brings valuable expertise and technology to complement PerkinElmer's existing portfolio.
Major companies operating in the high throughput screening (HTS) market report are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc., Biomat Srl, Diana Biotechnologies s.r.o.
North America was the largest region in the high throughput screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the high throughput screening (HTS) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
High-throughput screening (HTS) is a technique employed in drug discovery and various scientific domains to rapidly assess a large number of samples for biological activity. Its purpose is to identify active compounds, antibodies, or genes that modulate specific biological pathways, thereby expediting the drug discovery process.
The main types of products and services in high-throughput screening (HTS) are consumables and reagents, instruments, software, and services. Consumables and reagents refer to the materials and chemicals used in the screening process, including sample containers, assay reagents, and other disposable items necessary for experimental procedures. The technology types are categorized into ultra-high-throughput screening, cell-based assays, lab-on-a-chip, and label-free technology, which are used in several applications such as target identification and validation, primary and secondary screening, toxicology assessment, and others. The end users include the pharmaceutical and biotechnology industries, academic and research institutes, contract research organizations, and others.
The high throughput screening (HTS) research report is one of a series of new reports that provides high throughput screening (HTS) market statistics, including the high throughput screening (HTS) industry's global market size, regional shares, competitors with an High throughput screening (HTS) market share, detailed high throughput screening (HTS) market segments, market trends and opportunities, and any further data you may need to thrive in the high throughput screening (HTS) industry. This high throughput screening (HTS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The high-throughput screening (HTS) market consists of revenues earned by entities by providing services such as compound library screening, assay design and adaptation, and pilot screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-throughput screening (HTS) market also includes sales of lab equipment and supplies, chemicals, assay development tools, and data processing software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The high throughput screening market size is expected to see strong growth in the next few years. It will grow to $33.1 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth in the forecast period can be attributed to several key factors, including the expansion of the market size and growth rate, strategic initiatives undertaken by key industry players, a rising demand for disease monitoring and drug discovery solutions, the increasing prevalence of chronic diseases globally, and a growing emphasis on implementing ultra-high-throughput screening (UHTS) techniques. Major trends expected during this period include technological advancements in high-throughput screening methodologies and an increasing focus on the adoption of ultra-high-throughput screening (UHTS) techniques to enhance efficiency and throughput in various research and development processes.
The expansion in chronic illness prevalence is anticipated to drive the progression of the high-throughput screening (HTS) market in the future. Chronic diseases denote prolonged health conditions persisting over three months or more. HTS facilitates swift examination of numerous chemical compounds to identify potential drug candidates aimed at specific pathways or mechanisms linked to chronic ailments, crucial for their effective long-term control. For example, as per a report released by the National Library of Medicine in January 2023, the projected rise in individuals aged 50 and above with one or more chronic diseases in the United States is expected to soar by 99.5%, reaching 142.66 million by 2050, compared to 71.522 million in 2020.
Prominent enterprises operating within the high-throughput screening market are innovating their product lines to cater to their clientele with advanced functionalities. A multimode plate reader (MPR) represents an advanced laboratory apparatus employed in high-throughput screening, analyzing biological and chemical samples in microplates by integrating multiple detection modes for various assays within a unified platform. For instance, in February 2023, PerkinElmer Inc., a United States-based MedTech firm, unveiled the EnVision Nexus system. Positioned as the swiftest and most sensitive multimode plate reader in the market, the EnVision Nexus system is expressly crafted for demanding high-throughput screening (HTS) applications to accelerate drug discovery endeavors. Boasting distinctive technology, including dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, alongside cutting-edge reagent kits, the platform furnishes researchers with unmatched assay flexibility, precision, velocity, and sensitivity. Outfitted with user-friendly features such as a plate stacker for 20 or 50 plates and full automation and integration for uninterrupted 24/7 workflow-driven operations, the EnVision Nexus system empowers researchers to efficiently screen millions of samples with unprecedented efficiency.
In December 2023, PerkinElmer Inc., a prominent US-based MedTech firm, completed the acquisition of Covaris Inc. for an undisclosed sum. This strategic move is expected to expedite Covaris' growth trajectory, while simultaneously enabling PerkinElmer to broaden its footprint in the burgeoning diagnostics segment within the life sciences industry. Covaris Inc., renowned for its high-throughput screening solutions, brings valuable expertise and technology to complement PerkinElmer's existing portfolio.
Major companies operating in the high throughput screening (HTS) market report are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc., Biomat Srl, Diana Biotechnologies s.r.o.
North America was the largest region in the high throughput screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the high throughput screening (HTS) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
High-throughput screening (HTS) is a technique employed in drug discovery and various scientific domains to rapidly assess a large number of samples for biological activity. Its purpose is to identify active compounds, antibodies, or genes that modulate specific biological pathways, thereby expediting the drug discovery process.
The main types of products and services in high-throughput screening (HTS) are consumables and reagents, instruments, software, and services. Consumables and reagents refer to the materials and chemicals used in the screening process, including sample containers, assay reagents, and other disposable items necessary for experimental procedures. The technology types are categorized into ultra-high-throughput screening, cell-based assays, lab-on-a-chip, and label-free technology, which are used in several applications such as target identification and validation, primary and secondary screening, toxicology assessment, and others. The end users include the pharmaceutical and biotechnology industries, academic and research institutes, contract research organizations, and others.
The high throughput screening (HTS) research report is one of a series of new reports that provides high throughput screening (HTS) market statistics, including the high throughput screening (HTS) industry's global market size, regional shares, competitors with an High throughput screening (HTS) market share, detailed high throughput screening (HTS) market segments, market trends and opportunities, and any further data you may need to thrive in the high throughput screening (HTS) industry. This high throughput screening (HTS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The high-throughput screening (HTS) market consists of revenues earned by entities by providing services such as compound library screening, assay design and adaptation, and pilot screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-throughput screening (HTS) market also includes sales of lab equipment and supplies, chemicals, assay development tools, and data processing software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. High Throughput Screening (HTS) Market Characteristics3. High Throughput Screening (HTS) Market Trends And Strategies32. Global High Throughput Screening (HTS) Market Competitive Benchmarking33. Global High Throughput Screening (HTS) Market Competitive Dashboard34. Key Mergers And Acquisitions In The High Throughput Screening (HTS) Market
4. High Throughput Screening (HTS) Market - Macro Economic Scenario
5. Global High Throughput Screening (HTS) Market Size and Growth
6. High Throughput Screening (HTS) Market Segmentation
7. High Throughput Screening (HTS) Market Regional And Country Analysis
8. Asia-Pacific High Throughput Screening (HTS) Market
9. China High Throughput Screening (HTS) Market
10. India High Throughput Screening (HTS) Market
11. Japan High Throughput Screening (HTS) Market
12. Australia High Throughput Screening (HTS) Market
13. Indonesia High Throughput Screening (HTS) Market
14. South Korea High Throughput Screening (HTS) Market
15. Western Europe High Throughput Screening (HTS) Market
16. UK High Throughput Screening (HTS) Market
17. Germany High Throughput Screening (HTS) Market
18. France High Throughput Screening (HTS) Market
19. Italy High Throughput Screening (HTS) Market
20. Spain High Throughput Screening (HTS) Market
21. Eastern Europe High Throughput Screening (HTS) Market
22. Russia High Throughput Screening (HTS) Market
23. North America High Throughput Screening (HTS) Market
24. USA High Throughput Screening (HTS) Market
25. Canada High Throughput Screening (HTS) Market
26. South America High Throughput Screening (HTS) Market
27. Brazil High Throughput Screening (HTS) Market
28. Middle East High Throughput Screening (HTS) Market
29. Africa High Throughput Screening (HTS) Market
30. High Throughput Screening (HTS) Market Competitive Landscape And Company Profiles
31. High Throughput Screening (HTS) Market Other Major And Innovative Companies
35. High Throughput Screening (HTS) Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
High Throughput Screening (HTS) Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on high throughput screening (HTS) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for high throughput screening (HTS) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The high throughput screening (HTS) market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Products And Services: Consumables And Reagents; Instruments; Software And Services2) By Technology: Ultra-High-Throughput Screening; Cell-Based Assays; Lab-on-a-chip; Label-Free Technology.
3) By Application: Target Identification And Validation; Primary And Secondary Screening; Toxicology Assessment; Other Applications.
4) By End User: Pharmaceuticals And Biotechnology Industry; Academics And Research Institute; Contract Research Organization; Other End Users.
Key Companies Mentioned: Thermo Fisher Scientific Inc.; AstraZeneca Plc; Danaher Corporation; Merck Group; GE HealthCare Technologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Thermo Fisher Scientific Inc.
- AstraZeneca Plc
- Danaher Corporation
- Merck Group
- GE HealthCare Technologies Inc.
- Corning Inc.
- Agilent Technologies Inc.
- Lonza Group Ltd.
- Charles River Laboratories International Inc
- Beckman Coulter Inc.
- PerkinElmer Inc.
- Bio-Rad Laboratories
- Tecan Group Ltd.
- Sygnature Discovery Ltd.
- Luminex Corporation
- Hamilton Company
- Crown Bioscience Inc.
- HighRes Biosolutions
- NanoTemper Technologies GmbH
- BMG LABTECH GmbH
- Axxam SpA
- Reprocell Inc.
- BioTek Instruments Inc
- Aurora Biomed Inc.
- Cyclica Inc.
- Biomat Srl
- Diana Biotechnologies s.r.o
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | April 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 22.98 Billion |
| Forecasted Market Value ( USD | $ 33.1 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
